The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
about
Inhaled mannitol for cystic fibrosisTiming of hypertonic saline inhalation for cystic fibrosisInhaled mannitol for cystic fibrosisSafety assessment of inhaled xylitol in mice and healthy volunteersOptimising inhaled mannitol for cystic fibrosis in an adult populationCough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines.Airway-rehydrating agents for the treatment of cystic fibrosis: past, present, and future.Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway.Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.Quantitative imaging of airway liquid absorption in cystic fibrosis.Mucociliary clearance in cystic fibrosis.Hypertonic saline releases the attached small intestinal cystic fibrosis mucusPharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseImpact of Cardiopulmonary Bypass on Respiratory Mucociliary Function in an Experimental Porcine ModelMucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.Hyper-osmolarity and calcium chelation: Effects on cystic fibrosis mucus.Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial.Inhaled mannitol in cystic fibrosis.Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis.Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.Regulation of airway mucosal hydration.Inhaled mannitol for the treatment of cystic fibrosis.Mannitol dry powder for inhalation: in patients with cystic fibrosis.Effect of inhaled dry powder mannitol on mucus and its clearance.New pulmonary therapies directed at targets other than CFTR.Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis.Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.Timing of hypertonic saline inhalation for cystic fibrosis.Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder.Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.Hypertonic saline therapy in cystic fibrosis: Evidence against the proposed mechanism involving aquaporins.Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?Inhaled mannitol as a test for bronchial hyper-responsiveness.Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model.Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.Hypertonic saline in treatment of pulmonary disease in cystic fibrosis
P2860
Q24186558-156AAE7E-30F0-46C2-A0FA-A94E11E42AD0Q24203708-68A969F1-347A-4777-B1C8-2367E79B69A7Q24236723-B259424B-62BD-4873-B328-B64394974FB3Q24799101-E8CF3DF3-3EC3-4E3B-955A-AD803D3664DAQ26797457-E4252186-A989-4CCA-A282-3B8A62CA5AA1Q33232255-F5ADB990-CD97-4506-9658-9AE716580FF7Q33771660-84A487A2-925A-4924-8720-1F04408299A5Q33840919-952B95A7-46A4-4475-AD8F-0DD9A3EA96E2Q33916434-58FDC5BF-8E41-4064-A7BB-FF06E4C01D45Q34115805-92E62EB3-79E3-483E-8BEB-E1DC1518C279Q34581003-58A489FE-E418-4900-A39C-BBFE6842041FQ35004229-F14BDF49-F475-4C75-BD89-B1B647C56E98Q35164509-C6E18E15-CBE1-4FF4-8345-B3623A91D644Q35750282-8ED69240-A652-4803-9EB7-6B2C2F0E323BQ36053855-DA6E9128-727F-4105-896C-64032966F36DQ36144853-8AB6E849-6411-482D-AC0D-9C6DF70ACCB5Q36246683-92EF5DEB-4614-41F6-BC59-072D32AD768AQ36861632-FA35883F-D116-45E3-A7B1-8819D54B8586Q36982086-F7EC3D85-8AE2-46BA-8411-93EAFA778872Q37158668-B8F20B9A-34C0-4738-8525-34866C773F9AQ37439845-CF8F1D80-37DF-4C92-A534-69B7B3369714Q37849777-07F9D9C4-C76C-4023-AA75-2FE30A7E3EE6Q37960092-5D4826CA-D4C1-4B72-9664-923144135DB7Q37979246-6C9945C7-1641-42CA-BC3E-FFEB2A91452CQ38023470-D5EAA495-7968-46C6-A1DC-8D13C959823EQ38077798-A46BCD75-8E47-443E-A4BC-2039A8473F4CQ38111645-0C3A6997-CE7C-445A-8919-5E66B1442695Q38153821-ED68718F-229E-4801-B3DC-9B5D5B288727Q38325672-084F02D3-309C-4D3C-B55F-E37C60FF628DQ38986450-73B40E2B-48B3-41A0-8BFE-ADD70AFE7066Q39225097-11497093-2023-4F44-A679-DAD7C8B3D7F3Q41729344-9BE7D7FC-E1BE-44C3-A01A-9397E1C79E5FQ41975470-D3DD705E-CA38-4AB6-B5F7-1D1158F325E6Q42497993-A08A5C01-9C85-4728-B1A9-24103A4A8655Q42732058-A28FBFA6-1025-4BEF-BCA2-AC60A11FF501Q43061633-FE463900-535A-4802-B796-5E4334FFE5F8Q45082881-C96AD47A-6C58-42C8-8685-857D49C2F48EQ45250841-1DC7625A-7594-43EC-A061-9331BF2EAEF0Q46274587-2A5FA32E-4CD0-422B-8D6F-0EA723C2743BQ58914917-068743A0-F404-4AEB-A4F1-FC1A679DA625
P2860
The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@ast
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@en
type
label
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@ast
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@en
prefLabel
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@ast
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@en
P2093
P1476
The effect of inhaled mannitol ...... rosis patients: a pilot study.
@en
P2093
E Daviskas
M Robinson
S D Anderson
P304
P356
10.1034/J.1399-3003.1999.14C30.X
P577
1999-09-01T00:00:00Z